FDA approves first flu vaccine that can be self-administered at …
WEB2 days ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
No needles required: The FDA approves an at-home flu vaccine
WEB2 days ago · FluMist itself is not new — the live attenuated influenza vaccine has had FDA approval for more than two decades. But the ability for adults to order the vaccine at home to administer to people ages 2 to 49 is a breakthrough in convenience and access to preventative care. ... Health News Florida Partners.
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine …
WEBAug 16, 2024 · Pfizer also provides update on its separate Phase 2 second-generation trivalent influenza mRNA vaccine trial which showed encouraging data demonstrating robust immunogenicity against all strains compared to a standard of care influenza vaccine
Next-generation influenza vaccines based on mRNA technology
WEB4 days ago · Thus, in The Lancet Infectious Diseases, Dense Hsu and colleagues 8 report the interim results of a safety and immunogenicity study of a panel of next-generation mRNA influenza vaccines that targeted an additional one or two influenza H3N2 strains in adults aged 50–75 years. All vaccines included the A/Darwin/6/2021 (H3N2) strain (subclade 3C.2a1b.2a.2a), one next-generation vaccine ...
Study shows promise for a universal influenza vaccine: Scientists ...
WEBJul 19, 2024 · New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime...
HHS provides $176 million to develop pandemic influenza mRNA-based vaccine
WEBJul 2, 2024 · This award will enable the rapid development of an mRNA vaccine targeted to various influenza virus subtypes, also known as strains, of pandemic potential. The award also includes the option for large-scale production and pandemic response.
Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
WEBSep 14, 2022 · First Phase 3 efficacy study to be conducted using an mRNA-based influenza vaccine; study will enroll 25,000 U.S. adults 18 years and older. Influenza causes 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths in the U.S. every year1. mRNA-based vaccines require only the genetic sequences of …
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
WEBOct 26, 2023 · NEW YORK & MAINZ, GERMANY-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age.
Combined COVID–flu vaccines are coming: Moderna jab clears
WEBJun 28, 2024 · A single vaccine has been shown to protect people from both SARS-CoV-2 and influenza viruses — and with a higher effectiveness than vaccines that target one or the other, the pharmaceutical company...
FDA Approves Nasal Spray Influenza Vaccine for Self- or …
WEB2 days ago · Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes ...
- Some results have been removed
Skip to content